Stem definition | Drug id | CAS RN |
---|---|---|
antihypertensives, guanidine derivatives | 1339 | 40580-59-4 |
None
Property | Value | Reference |
---|---|---|
MRTD (Maximum Recommended Therapeutic Daily Dose) | 18.48 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 85 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 29, 1982 | FDA | PHARMACIA AND UPJOHN |
None
None
None
None
Source | Code | Description |
---|---|---|
MeSH PA | D000959 | Antihypertensive Agents |
MeSH PA | D002317 | Cardiovascular Agents |
CHEBI has role | CHEBI:35674 | antihypertensive drugs |
CHEBI has role | CHEBI:37887 | adrenergic blockers |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Hypertensive disorder | indication | 38341003 | DOID:10763 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.82 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Sodium-dependent noradrenaline transporter | Transporter | SUBSTRATE | DRUGBANK | CHEMBL | |||||
Alpha-1A adrenergic receptor | GPCR | WOMBAT-PK |
ID | Source |
---|---|
4019769 | VUID |
N0000179147 | NUI |
D00607 | KEGG_DRUG |
22195-34-2 | SECONDARY_CAS_RN |
4018079 | VANDF |
4019769 | VANDF |
C0061938 | UMLSCUI |
CHEBI:5555 | CHEBI |
CHEMBL1037 | ChEMBL_ID |
DB00226 | DRUGBANK_ID |
CHEMBL3184143 | ChEMBL_ID |
38521 | PUBCHEM_CID |
C004945 | MESH_SUPPLEMENTAL_RECORD_UI |
7193 | IUPHAR_LIGAND_ID |
2590 | INN_ID |
765C9332T4 | UNII |
217653 | RXNORM |
1821 | MMSL |
4807 | MMSL |
d00725 | MMSL |
000641 | NDDF |
004494 | NDDF |
14013006 | SNOMEDCT_US |
372820001 | SNOMEDCT_US |
69204002 | SNOMEDCT_US |
None